



PRODUCT TYPES
Solutions
Suspensions
Emulsions
Suspensions
Emulsions
PRODUCT MARKET
Inhalation
Ophthalmic
Otic
Oral
Ophthalmic
Otic
Oral
CONTAINER TYPES
Inhalation
Ear Drops
Eye Drops
Unique Patented Designs
Ear Drops
Eye Drops
Unique Patented Designs

1995
TRC (formerly Holopack International) founded in Columbia SC
2000
TRC receives FDA approval to manufacture & distribute drug products
2003
TRC obtains first ANDA
2005
Installation of Rommelag 460 and automated packaging line Capacity of 500 Million units
2008
TRC obtains second ANDA and has an annual capacity of 700 Million units
2009
Olympus Partners acquires Holopack International and forms The Ritedose Corporation
2012
TRC obtains third ANDA
2013
EU compliant expansion Quality & Development Lab expansion
2016
TRC obtains fourth ANDA and has an annual capacity of 1.7 Billion units with 10 BFS machines, 4 fully automatic packaging lines and 1 semi-automatic packing line
2017
TRC acquired by international investors led by private equity firms based in the U.S. and Hong Kong
2018
Plant expansion of over 150,000 sq ft for packaging and distribution
2019
TRC registers with FDA as a 503B Outsourcing and Repackaging Facility
-
Jody Chastain
Chief Executive Officer -
Uday Doshi
VP of Scientific Affairs -
Steven Franchak
Chief Financial Officer -
Angie Koen
Vice President of Technical Services -
Mohammad Sadeghi
Vice President of Quality -
Shawn Collins
Vice President of Operations -
Ken Weems
503B Operations Manager -
Julia Bales
503B Pharmacist In Charge -
Carol Morgan
Business Development -
Lori Wedemyer
Director of Human Resources -
Shawn Miller
Chief Information Officer